PAS
RAPT

Point72 Asia (Singapore)’s RAPT Therapeutics RAPT Stock Holding History

Point72 Asia (Singapore)’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-575
Closed -$14K – 1252
2024
Q2 		$14K Sell
575
-383
-40% -$17.7K ﹤0.01% 885
2024
Q1 		$68.8K Buy
+958
New +$133K 0.02% 736

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Asia (Singapore)'s RAPT Position: Q3 2024 in Review

Point72 Asia (Singapore) sold out of RAPT Therapeutics (RAPT) in Q3 2024, closing a stake of 575 shares — an estimated $14K sold.

Point72 Asia (Singapore) first reported a position in RAPT in Q1 2024 and held it in 2 quarters. The position peaked at $68.8K in Q1 2024. 94 funds tracked by Wall St. Rank hold RAPT as of Q3 2024.

  • Point72 Asia (Singapore) reported no remaining RAPT Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 575 RAPT Therapeutics shares in Q3 2024, an estimated $14K.
  • Point72 Asia (Singapore) first reported a position in RAPT Therapeutics in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s RAPT Therapeutics position peaked at $68.8K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2024, filed 14 Nov 2024.